Name:
Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine)
Type:
Opioid
AKA:
N/A
Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) image
Synthetic substance, no natural derivative
IUPAC Logo
Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) image
Metonitazene, a synthetic opioid, was developed in the 2010s. It is known for its potent analgesic effects and has been studied for its potential in pain management. Its high potency and potential for abuse have led to strict regulations.
Synthetic Substances Image
Metonitazene is a potent synthetic opioid with strong analgesic effects. As a downer, it provides significant pain relief and sedation. Short-term effects include reduced pain and euphoria, while long-term use can lead to dependence and tolerance. Overdose risks involve severe respiratory depression and potential fatality. Safe dosing requires medical supervision. Recent research focuses on its efficacy and risks of misuse.
N/A
Metonitazene, an opioid receptor agonist, provides intense euphoria and cognitive impairment. Immediate effects include mood enhancement and pain relief, while long-term use can lead to severe dependence and psychological issues such as depression. Effects last several hours, with risks of significant mental health disturbances and cognitive decline with chronic use.
N/A
Metonitazene is a synthetic opioid with no historical lore, emerging in the late 20th century. Its significance is tied to discussions about opioid potency and addiction. Proponents focus on its pain-relief capabilities, while opponents warn of severe addiction risks and health issues. Its use is primarily medicinal, reflecting broader debates in opioid management.
N/A